Event Monitor
Sign in
Monitor · Disease outbreak
Reported

Ebola vaccine clinical trial begins in DR Congo

A clinical trial evaluating Ebola vaccines has started in the Democratic Republic of the Congo. One trial involves Ervebo, a vaccine approved against the Zaire strain, to assess whether it provides cross-protection against the Bundibugyo strain, alongside tests of multiple vaccines for safety, efficacy, and immunogenicity. It is not yet reported how many participants will be enrolled or when initial findings will be released.

Follow this storyWe write to you when this story changes – not for everything we publish.
The sources disagree.
Each position is reported as its publisher stated it. We do not reconcile them.
2 differing positions reported on status across 4 publishers; unresolved.
  • thehindubegins
  • aljazeeraannounces
  • folhainicia
  • cgtnbegins
WhereDemocratic Republic of the Congo
-4.717, 20.234 ±400 km
First reported29 hours ago
Published2026-10-24 01:10 UTC
Sources4
How this travelled.
Reports4Independent tellings4
4 independently corroborated tellings.

Corrections and updates

No published correction or update is recorded. This does not reconstruct changes made before correction records were kept.

Cite this record

Global Event Monitor. Ebola vaccine clinical trial begins in DR Congo. 2026-10-24T01:10:03.159Z. Status: published. urn:global-events-monitor:event:7283. https://global.eventmonitor.net/event/2026-10-24/ebola-vaccine-trial-begins-in-dr-congo-54c29f65

BibTeX · RIS · CSV · JSON · Corrections and updates · Captured versions

/event/2026-10-24/ebola-vaccine-trial-begins-in-dr-congo-54c29f65 Back to the stream

Ask about this event